The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it remains still orphan of an adequate therapeutic strategy. Herein we focus on the interplay between oxidative stress (OS) and the other causal pathogenetic factors. Different reactive oxygen species (ROS) generators contribute to NAFLD inflammatory and fibrotic progression, which is quite strictly linked to the lipotoxic liver injury from fatty acids and/or a wide variety of their biologically active metabolites in the context of either a two-hit or a (more recent) multiple parallel hits theory. An antioxidant defense system is usually able to protect hepatic cells from damaging effects caused by ROS, including those produced into the gastrointestinal tract, i.e., by-products generated by usual cellular metabolic processes, normal or dysbiotic microbiota, and/or diet through an enhanced gut–liver axis. Oxidative stress originating from the imbalance between ROS generation and antioxidant defenses is under the influence of individual genetic and epigenetic factors as well. Healthy diet and physical activity have been shown to be effective on NAFLD also with antioxidant mechanisms, but compliance to these lifestyles is very low. Among several considered antioxidants, vitamin E has been particularly studied; however, data are still contradictory. Some studies with natural polyphenols proposed for NAFLD prevention and treatment are encouraging. Probiotics, prebiotics, diet, or fecal microbiota transplantation represent new therapeutic approaches targeting the gut microbiota dysbiosis. In the near future, precision medicine taking into consideration genetic or environmental epigenetic risk factors will likely assist in further selecting the treatment that could work best for a specific patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Oxidative stress: a concept in redox biology and medicine
Sies, H. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.002 · Cited by 2,991
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · cited 2×
“Most recent evidences underline that inflammation may even precede fat accumulation, which would become only a response (12, 13).”
BackgroundHalliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949 · cited 1×
“Non-enzymatic Anti-oxidants Defenses Antioxidants are substances that inhibit the oxidation of any biomolecule (102), neutralizing the harmful effects of oxidation caused by free radicals, maintaining therefore the redox homeostasis.”
BackgroundGut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 1×
“, Escherichia genus members of the Proteobacteria phylum induced by highfat diet; (90)] is able to induce the formation of ROS by HSC cells and impair intestinal integrity.”
BackgroundRole of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Chen, Z., Tian, R., She, Z., Cai, J., & Li, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.025 · Cited by 1,279
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
Reactive oxygen species, cell signaling, and cell injury
Hensley, K., Robinson, K. A., Gabbita, S. P., Salsman, S., & Floyd, R. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00252-5 · Cited by 1,019
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
Gambini, J., Inglés, M., Olaso, G., Lopez-Grueso, R., Bonet-Costa, V., Gimeno-Mallench, L., Mas-Bargues, C., Abdelaziz, K. M., Gomez-Cabrera, M. C., Vina, J., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/837042 · Cited by 737
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734 · cited 1×
“In NASH, there are more evidences ofmitochondrial DNA and protein abnormalities being responsible for the increase of OS (38, 39).”
BackgroundVitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
A gut-vascular barrier controls the systemic dissemination of bacteria
Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Caprioli, F., Bottiglieri, L., Oldani, A., Viale, G., et al. (2015) · Science · doi:10.1126/science.aad0135 · Cited by 695
Song, B., Scheuner, D., Ron, D., Pennathur, S., & Kaufman, R. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34587 · Cited by 693
Obesity, Diabetes, and Gut Microbiota
Musso, G., Gambino, R., & Cassader, M. (2010) · Diabetes Care · doi:10.2337/dc10-0556 · Cited by 665
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Degradation of Misfolded Proteins Prevents ER-Derived Oxidative Stress and Cell Death
Haynes, C. M., Titus, E. A., & Cooper, A. A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.025 · Cited by 627
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586 · cited 1×
“• increased endoplasmic reticulum oxidoreduction-1 (ERO-1) activity, the enzyme that catalyzes disulfide bond formation (53) with H2O2 production; • upregulation of CCAAT/enhancer-binding protein homologous protein (Chop), a proapoptotic mechanism (54); • calcium leakage from ER, which increases its flow through mitoc…”
BackgroundChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 585
Redox signaling in hypertension
PARAVICINI, T., & TOUYZ, R. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.001 · Cited by 577
Gut microbiota and metabolic syndrome
Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Gillessen, A., & Schmidt, H. H.-J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01251-y · Cited by 490
Rector, R. S., Thyfault, J. P., Uptergrove, G. M., Morris, E. M., Naples, S. P., Borengasser, S. J., Mikus, C. R., Laye, M. J., Laughlin, M. H., Booth, F. W., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.030 · Cited by 488
Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipour, M., Feizi, A., & Sahebkar, A. (2016) · Phytotherapy Research · doi:10.1002/ptr.5659 · Cited by 460
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Exercise and Hormesis: Activation of Cellular Antioxidant Signaling Pathway
JI, L. L., GOMEZ‐CABRERA, M., & VINA, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.061 · Cited by 450
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
Lactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease)
Nanji, A. A., Khettry, U., & Sadrzadeh, S. M. H. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43703 · Cited by 436
Pathogenesis of steatohepatitis
Day, C. P. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0333 · Cited by 431
Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin
Bokoch, G. M., & Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90008-4 · Cited by 422
Berson, A., De Beco, V., Lettéron, P., Robin, M. A., Moreau, C., Kahwaji, J. E., Verthier, N., Feldmann, G., Fromenty, B., & Pessayre, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70590-6 · Cited by 405
Forsyth, C. B., Farhadi, A., Jakate, S. M., Tang, Y., Shaikh, M., & Keshavarzian, A. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.12.009 · Cited by 394
Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous?
Kruidenier, L., & Verspaget, H. W. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01378.x · Cited by 392
Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1571114 · Cited by 379
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373 · cited 1×
“The oxidative hepatic environment in obesity furthermore promotes the signal transduction and activation of transcription programs (STAT-1 and STAT-3) that promote T-cell recruitment and liver damage with disease progression up to its malignant transformation [(48); Figure 1].”
BackgroundReactive oxygen species, nutrition, hypoxia and diseases: Problems solved?
Görlach, A., Dimova, E. Y., Petry, A., Martínez-Ruiz, A., Hernansanz-Agustín, P., Rolo, A. P., Palmeira, C. M., & Kietzmann, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.016 · Cited by 351
Oxidative Stress and Antioxidants in Hypertension–A Current Review
Sinha, N., & Dabla, P. (2015) · Current Hypertension Reviews · doi:10.2174/1573402111666150529130922 · Cited by 350
Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients With Nonalcoholic Steatohepatitis
Chalasani, N., Gorski, C. J., Asghar, M. S., Asghar, A., Foresman, B., Hall, S. D., & Crabb, D. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50095 · Cited by 348
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity‐related Liver Disease
Vajro, P., Mandato, C., Licenziati, M. R., Franzese, A., Vitale, D. F., Lenta, S., Caropreso, M., Vallone, G., & Meli, R. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31821f9b85 · Cited by 341
Self-citationAberrant gut microbiota composition at the onset of type 1 diabetes in young children
de Goffau, M. C., Fuentes, S., van den Bogert, B., Honkanen, H., de Vos, W. M., Welling, G. W., Hyöty, H., & Harmsen, H. J. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3274-0 · Cited by 326
The role of oxidative stress in non-alcoholic steatohepatitis
Koek, G. H., Liedorp, P. R., & Bast, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.013 · Cited by 314
Ashraf, N. U., & Sheikh, T. A. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1078461 · Cited by 310
Evstatiev, R., & Gasche, C. (2012) · Gut · doi:10.1136/gut.2010.214312 · Cited by 293
Yang, J., Fernández-Galilea, M., Martínez-Fernández, L., González-Muniesa, P., Pérez-Chávez, A., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Nutrients · doi:10.3390/nu11040872 · Cited by 292
Role of mitochondria in non‐alcoholic fatty liver disease
Pessayre, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04640.x · Cited by 279
ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello, G., & Knaus, U. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13428 · Cited by 278
Regulation of the Immune System by the Resident Intestinal Bacteria
Kamada, N., & Núñez, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.060 · Cited by 269
Volynets, V., Küper, M. A., Strahl, S., Maier, I. B., Spruss, A., Wagnerberger, S., Königsrainer, A., Bischoff, S. C., & Bergheim, I. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2112-9 · Cited by 268
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
Mesarwi, O. A., Loomba, R., & Malhotra, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1109tr · Cited by 263
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Tomaro-Duchesneau, C., Coussa-Charley, & Rodes (2011) · Biologics: Targets and Therapy · doi:10.2147/btt.s19099 · Cited by 256
Endocrine-disrupting chemicals and fatty liver disease
Foulds, C. E., Treviño, L. S., York, B., & Walker, C. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.42 · Cited by 252
Xu, M.-X., Ge, C.-X., Qin, Y.-T., Gu, T.-T., Lou, D.-S., Li, Q., Hu, L.-F., Feng, J., Huang, P., & Tan, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.016 · Cited by 246
miRNAs and NAFLD: from pathophysiology to therapy
Gjorgjieva, M., Sobolewski, C., Dolicka, D., Correia de Sousa, M., & Foti, M. (2019) · Gut · doi:10.1136/gutjnl-2018-318146 · Cited by 241
Trappoliere, M., Caligiuri, A., Schmid, M., Bertolani, C., Failli, P., Vizzutti, F., Novo, E., Manzano, C. D., Marra, F., Loguercio, C., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.023 · Cited by 238
D-livering the message: The importance of vitamin D status in chronic liver disease
Kitson, M. T., & Roberts, S. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.033 · Cited by 237
Namikawa, C., Shu-Ping, Z., Vyselaar, J. R., Nozaki, Y., Nemoto, Y., Ono, M., Akisawa, N., Saibara, T., Hiroi, M., Enzan, H., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.028 · Cited by 234
Structure of Ero1p, Source of Disulfide Bonds for Oxidative Protein Folding in the Cell
Gross, E., Kastner, D. B., Kaiser, C. A., & Fass, D. (2004) · Cell · doi:10.1016/s0092-8674(04)00418-0 · Cited by 230
Reactive Oxygen Production Induced by the Gut Microbiota: Pharmacotherapeutic Implications
Jones, R. M., Mercante, J. W., & Neish, A. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799828283 · Cited by 225
Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
Elvira-Torales, L. I., García-Alonso, J., & Periago-Castón, M. J. (2019) · Antioxidants · doi:10.3390/antiox8070229 · Cited by 219
Microbiota and Gut–Liver Axis: Their Influences on Obesity and Obesity‐Related Liver Disease
Vajro, P., Paolella, G., & Fasano, A. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318284abb5 · Cited by 201
Self-citationHoofnagle, J. H., Van Natta, M. L., Kleiner, D. E., Clark, J. M., Kowdley, K. V., Loomba, R., Neuschwander‐Tetri, B. A., Sanyal, A. J., Tonascia, J., & the Non‐alcoholic Steatohepatitis Clinical Research Network (NASH CRN) (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12352 · Cited by 201
Hardwick, R. N., Fisher, C. D., Canet, M. J., Lake, A. D., & Cherrington, N. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035006 · Cited by 200
Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease
García‐Ruiz, C., & Fernández‐Checa, J. C. (2018) · Hepatology Communications · doi:10.1002/hep4.1271 · Cited by 198
Thakur, V., Pritchard, M. T., McMullen, M. R., Wang, Q., & Nagy, L. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005613 · Cited by 196
Al-Serri, A., Anstee, Q. M., Valenti, L., Nobili, V., Leathart, J. B. S., Dongiovanni, P., Patch, J., Fracanzani, A., Fargion, S., Day, C. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.029 · Cited by 192
Vitamin E Treatment in Pediatric Obesity-Related Liver Disease: A Randomized Study
Vajro, P., Mandato, C., Franzese, A., Ciccimarra, E., Lucariello, S., Savoia, M., Capuano, G., & Migliaro, F. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200401000-00012 · Cited by 189
Self-citationClemente, M. G., Mandato, C., Poeta, M., & Vajro, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8078 · Cited by 188
Self-citationKamata, H., Manabe, T., Oka, S.-I., Kamata, K., & Hirata, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02712-6 · Cited by 179
Ore, A., & Akinloye, O. (2019) · Medicina · doi:10.3390/medicina55020026 · Cited by 179
Microbiota-mitochondria inter-talk: Consequence for microbiota-host interaction
Saint-Georges-Chaumet, Y., & Edeas, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftv096 · Cited by 176
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 174
Wang, J., He, W., Tsai, P.-J., Chen, P.-H., Ye, M., Guo, J., & Su, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01210-0 · Cited by 174
Banan, A., Choudhary, S., Zhang, Y., Fields, J. Z., & Keshavarzian, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35212-7 · Cited by 166
Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00296.2009 · Cited by 160
Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
Poeta, M., Pierri, L., & Vajro, P. (2017) · Children · doi:10.3390/children4080066 · Cited by 160
Self-citationProbiotics and prebiotics in chronic inflammatory bowel diseases
Ewaschuk, J. B. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i37.5941 · Cited by 159
Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches
Lomonaco, R., Sunny, N. E., Bril, F., & Cusi, K. (2013) · Drugs · doi:10.1007/s40265-012-0004-0 · Cited by 158
Celiac Disease and the Microbiome
Valitutti, F., Cucchiara, S., & Fasano, A. (2019) · Nutrients · doi:10.3390/nu11102403 · Cited by 157
Erhardt, A., Stahl, W., Sies, H., Lirussi, F., Donner, A., & Häussinger, D. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-2-76 · Cited by 152
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolašević, I., Filipec-Kanižaj, T., Mijić, M., Jakopčić, I., Milić, S., Hrstić, I., Sobočan, N., Štimac, D., & Burra, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i14.1491 · Cited by 148
Abenavoli, L., Greco, M., Milic, N., Accattato, F., Foti, D., Gulletta, E., & Luzza, F. (2017) · Nutrients · doi:10.3390/nu9080870 · Cited by 144
García‐Lezana, T., Raurell, I., Bravo, M., Torres‐Arauz, M., Salcedo, M. T., Santiago, A., Schoenenberger, A., Manichanh, C., Genescà, J., Martell, M., et al. (2018) · Hepatology · doi:10.1002/hep.29646 · Cited by 136
Tariq, Z., Green, C., & Hodson, L. (2014) · Liver International · doi:10.1111/liv.12523 · Cited by 132
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Jasirwan, C. O. M., Lesmana, C. R. A., Hasan, I., Sulaiman, A. S., & Gani, R. A. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-032 · Cited by 132
Effects of on genes expression pattern in small bowel mucosa
Caro, S. D., TAO, H., Grillo, A., Elia, C., Gasbarrini, A., Sepulveda, A. R., & Gasbarrini, A. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.12.008 · Cited by 130
Role of vitamin E in nonalcoholic fatty liver disease
Nagashimada, M., & Ota, T. (2018) · IUBMB Life · doi:10.1002/iub.1991 · Cited by 126
Navarro, V. J., Belle, S. H., D’Amato, M., Adfhal, N., Brunt, E. M., Fried, M. W., Reddy, K. R., Wahed, A. S., Harrison, S., & on behalf of the Silymarin in NASH and C Hepatitis (SyNCH) Study Group (2019) · PLoS ONE · doi:10.1371/journal.pone.0221683 · Cited by 125
Tan, T. C. H., Crawford, D. H., Jaskowski, L. A., Subramaniam, V. N., Clouston, A. D., Crane, D. I., Bridle, K. R., Anderson, G. J., & Fletcher, L. M. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.121 · Cited by 119
Antioxidant properties of ursodeoxycholic acid
Lapenna, D., Ciofani, G., Festi, D., Neri, M., Pierdomenico, S. D., Giamberardino, M. A., & Cuccurullo, F. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01391-6 · Cited by 116
Socha, P., Horvath, A., Vajro, P., Dziechciarz, P., Dhawan, A. K., & Szajewska, H. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818e04d1 · Cited by 111
Self-citationBell, L. N., Wang, J., Muralidharan, S. S., Chalasani, S., Fullenkamp, A. M., Wilson, L., Sanyal, A. J., Kowdley, K. V., Neuschwander‐Tetri, B. A., Brunt, E. M., et al. (2012) · Hepatology · doi:10.1002/hep.25805 · Cited by 107
The controversial role of vitamin D as an antioxidant: results from randomised controlled trials
Tagliaferri, S., Porri, D., Giuseppe, R. D., Manuelli, M. C., Alessio, F., & Cena, H. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000197 · Cited by 106
Musolino, V., Gliozzi, M., Scarano, F., Bosco, F., Scicchitano, M., Nucera, S., Carresi, C., Ruga, S., Zito, M. C., Maiuolo, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59485-3 · Cited by 103
The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease
Ben, M. D., Polimeni, L., Baratta, F., Pastori, D., & Angelico, F. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12899 · Cited by 100
Chashmniam, S., Mirhafez, S. R., Dehabeh, M., Hariri, M., Azimi–Nezhad, M., & Gh, B. F. N. M. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0386-5 · Cited by 97
Nobili, V., Donati, B., Panera, N., Vongsakulyanon, A., Alisi, A., Dallapiccola, B., & Valenti, L. V. C. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000279 · Cited by 90
Musso, G., Olivetti, C., Cassader, M., & Gambino, R. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1306426 · Cited by 88
Sundaram, S. S., Halbower, A. C., Pan, Z., Robbins, K. N., Capocelli, K. E., Klawitter, J., Shearn, C. T., & Sokol, R. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.010 · Cited by 85
Carvalho, M. M. D. F., Lage, N. N., Paulino, A. H. D. S., Pereira, R. R., Almeida, L. T., da Silva, T. F., Magalhães, C. L. D. B., de Lima, W. G., Silva, M. E., Pedrosa, M. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44563-y · Cited by 83
Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Mesa, M. D., Granados-Principal, S. M., Gil, Á., & Quiles, J. L. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.015 · Cited by 82
ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
Bellot, G. L., Liu, D., & Pervaiz, S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.06.007 · Cited by 81
Metabolic, Hormonal, Oxidative, and Inflammatory Factors in Pediatric Obesity-related Liver Disease
Mandato, C., Lucariello, S., Licenziati, M. R., Franzese, A., Spagnuolo, M. I., Ficarella, R., Pacilio, M., Amitrano, M., Capuano, G., Meli, R., et al. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.02.028 · Cited by 79
Self-citationFujii, J., Homma, T., Kobayashi, S., & Seo, H. G. (2018) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v9.i1.1 · Cited by 77
Abdel-Maboud, M., Menshawy, A., Menshawy, E., Emara, A., Alshandidy, M., & Eid, M. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820974917 · Cited by 75
The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
Li, S., Xu, Y., Guo, W., Chen, F., Zhang, C., Tan, H. Y., Wang, N., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00351 · Cited by 73
Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Baker, P. R., & Friedman, J. E. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120846 · Cited by 68
Lee, Y., Hu, S., Park, Y., & Lee, J. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.2.103 · Cited by 67
Li, Z., Zhang, H., Li, Y., Chen, H., Wang, C., Wong, V. K. W., Jiang, Z., & Zhang, W. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153209 · Cited by 66
Zhu, C.-G., Liu, Y.-X., Wang, H., Wang, B.-P., Qu, H., Wang, B.-L., & Zhu, M. J. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0542 · Cited by 64
Nobili, V., Alisi, A., Cutrera, R., Carpino, G., Stefanis, C. D., Doria, V., Vito, R. D., Cucchiara, S., Gaudio, E., & Musso, G. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-206782 · Cited by 59
Ding, S., Yuan, C., Si, B., Wang, M., Da, S., Bai, L., & Wu, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214680 · Cited by 55
Multiple gut–liver axis abnormalities in children with obesity with and without hepatic involvement
Nuzio, S. G., Stasi, M. D., Pierri, L., Troisi, J., Poeta, M., Bisogno, A., Belmonte, F., Tripodi, M. F., Salvio, D. D., Massa, G., et al. (2016) · Pediatric Obesity · doi:10.1111/ijpo.12164 · Cited by 52
Self-citationZhu, J.-B., Xu, S., Li, J., Song, J. H., Luo, B., Song, Y., Zhang, Z., Chen, Y., Xie, D., Yu, D., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.009 · Cited by 52
Clinical implications of understanding the association between oxidative stress and pediatric NAFLD
Mann, J. P., Raponi, M., & Nobili, V. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1291340 · Cited by 51
Wesolowski, S. R., Mulligan, C. M., Janssen, R. C., Baker, P. R., Bergman, B. C., D’Alessandro, A., Nemkov, T. G., Maclean, K. N., Jiang, H., Dean, T. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.008 · Cited by 51
Çakmak, E., Duksal, F., Altınkaya, E., Acıbucu, F., Doğan, Ö. T., Yönem, Ö., & Yılmaz, A. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.32655 · Cited by 50
Ganguli, S., Deleeuw, P., & Satapathy, S. K. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s188991 · Cited by 49
Zhang, L., Li, N., Robert, C. D., Fang, M.-Z., Liboni, K., McMahon, R., Caicedo, R. A., & Neu, J. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000221905.68781.4a · Cited by 48
Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
Taliento, A. E., Dallio, M., Federico, A., Prati, D., & Valenti, L. V. C. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152755 · Cited by 47
Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease
Tejada, S., Capó, X., Mascaró, C. M., Monserrat-Mesquida, M., Quetglas‐Llabrés, M. M., Pons, A., Tur, J. A., & Sureda, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200417165801 · Cited by 45
Varela, N., Quiñones, L. A., Myriam Orellana, B., Poníachik, J., Csendes, A., Smok, G., Rodrigo, R., Cáceres, D., & Videla, L. A. (2008) · Biological Research · doi:10.4067/s0716-97602008000100010 · Cited by 44
Vajro, P., Lenta, S., Pignata, C., Salerno, M., D’Aniello, R., Micco, I. D., Paolella, G., & Parenti, G. (2012) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-38-55 · Cited by 41
Self-citationLei, K., Li, Y., Wang, Y., Wen, J., Hong-zhao, W., Yu, D., & Li, W. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400342 · Cited by 40
Chang, H., Hsu, S., & Chien, C. (2019) · Antioxidants · doi:10.3390/antiox9010002 · Cited by 40
Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis
Zhang, L., She, Z., Li, H., & Zhang, X. (2020) · Clinical Science · doi:10.1042/cs20200446 · Cited by 40
Susceptibility of brown adipocytes to pro-inflammatory cytokine toxicity and reactive oxygen species
Rebiger, L., Lenzen, S., & Mehmeti, I. (2016) · Bioscience Reports · doi:10.1042/bsr20150193 · Cited by 38
Mirhafez, S. R., Farimani, A. R., Gholami, A., Hooshmand, E., Tavallaie, S., & Gh, B. F. N. M. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0040 · Cited by 37
Co-carcinogenic effects of vitamin E in prostate
Vivarelli, F., Canistro, D., Cirillo, S., Papi, A., Spisni, E., Vornoli, A., Croce, C. M. D., Longo, V. G., Franchi, P., Filippi, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48213-1 · Cited by 37
Kawahara, H., Fukura, M., Tsuchishima, M., & Takase, S. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00287.x · Cited by 36
Hall, K. T., Buring, J. E., Mukamal, K. J., Moorthy, M. V., Wayne, P. M., Kaptchuk, T. J., Battinelli, E. M., Ridker, P. M., Sesso, H. D., Weinstein, S. J., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy204 · Cited by 35
Yusuf, M., Khan, M., Robaian, M. A., & Khan, R. A. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0250 · Cited by 34
A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach
Sangouni, A. A., & Ghavamzadeh, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.063 · Cited by 30
Intestinal permeability and oxidative stress in patients with alcoholic pellagra
Junqueira‐Franco, M. V. M., Troncon, L. E. D. A., Chiarello, P. G., de Unamuno, M. D. R. D. L., Jordão, A. A., & Vannucchi, H. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.03.010 · Cited by 28
Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis
de Knegt, R. J. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201753265505 · Cited by 26
Nanocarrier-based antioxidant therapy: promise or delusion?
Weissig, V., & Guzman‐Villanueva, D. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1063611 · Cited by 25
Jorgačević, B. Z., Vučević, D. B., Samardžić, J., Mladenović, D. R., Vesković, M. N., Vukićević, D., Ješić, R., & Radosavljević, T. S. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200303122734 · Cited by 25
Parola, M., & Vajro, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.042 · Cited by 24
Self-citationThe endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease.
Gentile, C. L., & Pagliassotti, M. J. (2008) · PubMed · Cited by 23
Gottlieb, A., Mosthael, W., Sowa, J., & Canbay, A. E. (2018) · Digestion · doi:10.1159/000493259 · Cited by 23
Medina, O. P., Tower, R. J., Peñate-Medina, T., Ashkenani, F., Appold, L. C., Bötcher, M., Huber, L., Will, O., Ling, Q., Hauser, C., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200717084846 · Cited by 21
Genetic risk factors associated with NAFLD
Kim, D. Y., & Park, J. Y. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.96 · Cited by 20
Development of new drugs for the treatment of nonalcoholic steatohepatitis
Tang, J. T., & Ma, H. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12830 · Cited by 17
Pierri, L., Saggese, P., Nuzio, S. G., Troisi, J., Stasi, M. D., Poeta, M., Savastano, R., Marchese, G., Tarallo, R., Massa, G., et al. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.03.015 · Cited by 16
Self-citationThe Benefits of vitamin E on liver function and the hemopoietic System in thalassemia Patients.
Hashemian, Z., Hashemi, A., & Fateminasab, M. (2012) · PubMed Central · Cited by 5
Cited by
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 604
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Juanola, O., Martínez-López, S., Francés, R., & Gómez-Hurtado, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105227 · Cited by 302
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Sawada, K., Chung, H., Softic, S., Moreno-Fernandez, M. E., & Divanovic, S. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.009 · Cited by 139
Del Bo’, C., Perna, S., Allehdan, S., Rafique, A., Saad, S., AlGhareeb, F., Rondanelli, M., Tayyem, R. F., Marino, M., Martini, D., et al. (2023) · Nutrients · doi:10.3390/nu15102250 · Cited by 80
Metadata
- Authors
- Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-02-26
- Volume
- 8
- Pages
- 595371-595371
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3135028306
- Cited by
- 289
- References
- 161
- FWCI
- 29.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.